News
The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said ...
Modular Medical (Nasdaq:MODD) announced today that it validated its insulin pump cartridge line for human-use production in ...
Swiss entrepreneur Willy Michel, who founded Ypsomed, controls TecMed. His son, Simon Michel, is CEO of Ypsomed. Included in ...
Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor ...
Trividia Health announced today that it launched its new TRUEplus five-bevel insulin pen needle line in the UK.
Dexcom (Nadsaq:DXCM) today reported second-quarter financial results that came in ahead of the consensus forecast.
Trinity Biotech (Nasdaq:TRIB) announced today that it unveiled its new flagship continuous glucose monitor (CGM) biosensor ...
What has changed in the last year as diabetes technology developers continue to innovate and advance their offerings?
Stelo, the first FDA-cleared over-the-counter glucose biosensor, joins the G7 continuous glucose monitor (CGM) in offering ...
This notice comes just weeks after an initial warning about potential underinfusion with all Novum IQ large-volume pumps.
Tidepool announced that it began rolling out its new cloud-to-cloud integration with the Abbott (NYSE:ABT) FreeStyle Libre ...
Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results